WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.

导出 LinkOut

翻译打印收藏纠错

作者： Anling,Chen ^[1] ; Ke,Yin ^[2] ; Yu,Liu ^[3] ; Lei,Hu ^[4] ; Qianwen,Cui ^[5] ; Xiaofeng,Wan ^[1] ; Wulin,Yang ^[2]

作者单位： Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, China. ^[1] Science Island Branch, Graduate School of University of Science and Technology of China, Hefei, 230031, China. ^[2] Hefei Cancer Hospital, Chinese Academy of Sciences, Hefei, 230031, China. ^[3] School of Life Sciences, Bengbu Medical College, Bengbu, 233000, China. ^[4] School of Preclinical Medicine, Wannan Medical College, Wuhu, 241002, China. ^[5]

关键词 Adavosertib HCC Hepatocellular carcinoma RP-6306 Sorafenib Wee family kinase

DOI 10.2174/0115680096298370240520093003

PMID 38860904

发布时间 2024-06-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Current cancer drug targets

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.

Current cancer drug targets

相似文献

Current cancer drug targets

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

WEE Family Kinase Inhibitors Combined with Sorafenib Can Selectively Inhibit HCC Cell Proliferation.

Current cancer drug targets

相似文献

Current cancer drug targets

相关期刊

检索历史清除